Fidelity Investments’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Fidelity Investments’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-245,271	Closed	-$15.2M	–	5817
2023 Q4	$15.2M	Sell	245,271 -893,701	-78%	-$22.2M	﹤0.01%	1712
2023 Q3	$25.3M	Buy	+1,138,972	New	+$23.9M	﹤0.01%	1496

Fidelity Investments's RYZB Position: Q1 2024 in Review

Fidelity Investments sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 245,271 shares — an estimated $15.2M sold.

Fidelity Investments first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $25.3M in Q3 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Fidelity Investments reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Fidelity Investments sold 245,271 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $15.2M.
Fidelity Investments first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Fidelity Investments's RayzeBio, Inc. Common Stock position peaked at $25.3M in Q3 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.